(Q39804120)

14 September 2017

title

Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65. (English)

1 reference

14 September 2017

0 references

0 references

Shihui Li

1

1 reference

14 September 2017

Fang Xue

2

1 reference

14 September 2017

Zhiyong Cheng

3

1 reference

14 September 2017

Xiaoyang Yang

4

1 reference

14 September 2017

Suyun Wang

5

1 reference

14 September 2017

Fengyong Geng

6

1 reference

14 September 2017

Ling Pan

7

1 reference

14 September 2017

publication date

29 August 2009

1 reference

International Journal of Hematology

14 September 2017

published in

1 reference

14 September 2017

volume

90

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

513-521

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-009-0409-z

14 September 2017

exact match

0 references

cites work

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-009-0409-Z

The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma

21 January 2018

1 reference

12 December 2020

Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.

1 reference

12 December 2020

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

1 reference

12 December 2020

Molecular modes of action of artesunate in tumor cell lines.

1 reference

12 December 2020

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

1 reference

12 December 2020

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

12 December 2020

Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival

1 reference

12 December 2020

Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action

1 reference

12 December 2020

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

12 December 2020

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

1 reference

12 December 2020

Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents

1 reference

12 December 2020

The anti-malarial artesunate is also active against cancer

1 reference

12 December 2020

Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.

1 reference

12 December 2020

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

12 December 2020

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

12 December 2020

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

1 reference

12 December 2020

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

1 reference

12 December 2020

Novel Therapies in Multiple Myeloma

1 reference

12 December 2020

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

1 reference

12 December 2020

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

12 December 2020

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

1 reference

12 December 2020

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

1 reference

12 December 2020

Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation

1 reference

12 December 2020

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

12 December 2020

High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial

1 reference

12 December 2020

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

12 December 2020

s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line.

1 reference

12 December 2020

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

1 reference

12 December 2020

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

12 December 2020

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

12 December 2020

10.1007/S12185-009-0409-Z

Identifiers

DOI

1 reference

14 September 2017

1 reference